Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated Either With an Inactivated Influenza Vaccine Administered Via the Intradermal Route or an Inactivated Influenza Vaccine Administered Via the Intramuscular Route

Sanofi Pasteur, a Sanofi Company0 sites160 target enrollmentSeptember 2007

ConditionsInfluenza Orthomyxovirus Infections Myxovirus Infection

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Influenza
Sponsor: Sanofi Pasteur, a Sanofi Company
Enrollment: 160
Primary Endpoint: To provide information concerning immune response to an inactivated, split-virion, influenza vaccine.
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

To further characterize the immune responses induced after an influenza vaccination performed either via the ID or the IM routes in two clearly distinct populations.

Objectives:

To describe the immune response per age group and vaccine group after vaccination.
To describe the safety of the vaccines per age group and per vaccine group after vaccination.

Registry

clinicaltrials.gov

Start Date

September 2007

End Date

April 2009

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel